8,240 Clinical Drug Overviews
DISOPYRAMIDE PHOSPHATE
Other drugs that prolong the QT interval increase risk of torsades de pointes Can cause heart failure and severe anticholinergic side effects.
Antiarrhythmic (Class Ia)
DISPERMOX
Comprehensive clinical and safety monograph for DISPERMOX (DISPERMOX).
Penicillin Antibiotic
DISULFIRAM
Metronidazole and alcohol-containing products can cause a disulfiram-like reaction Can cause hepatotoxicity and psychiatric disturbances.
Aldehyde Dehydrogenase Inhibitor
DITATE-DS
Comprehensive clinical and safety monograph for DITATE-DS (DITATE-DS).
Corticosteroid
DITROPAN
Comprehensive clinical and safety monograph for DITROPAN (DITROPAN).
Anticholinergic
DITROPAN XL
Comprehensive clinical and safety monograph for DITROPAN XL (DITROPAN XL).
DIUCARDIN
Comprehensive clinical and safety monograph for DIUCARDIN (DIUCARDIN).
Thiazide Diuretic
DIULO
Comprehensive clinical and safety monograph for DIULO (DIULO).
DIUPRES-250
Comprehensive clinical and safety monograph for DIUPRES-250 (DIUPRES-250).
Antihypertensive Combination
DIUPRES-500
Comprehensive clinical and safety monograph for DIUPRES-500 (DIUPRES-500).
DIURIL
Comprehensive clinical and safety monograph for DIURIL (DIURIL).
DIUTENSEN-R
Comprehensive clinical and safety monograph for DIUTENSEN-R (DIUTENSEN-R).
DIVALPROEX SODIUM
CYP450 enzyme inducers may decrease levels Can cause severe hepatotoxicity and teratogenic effects including neural tube defects.
Anticonvulsant
DIVIGEL
Comprehensive clinical and safety monograph for DIVIGEL (DIVIGEL).
Estrogen
DIZAC
Comprehensive clinical and safety monograph for DIZAC (DIZAC).
Benzodiazepine
DOBUTAMINE HYDROCHLORIDE
Comprehensive clinical and safety monograph for DOBUTAMINE HYDROCHLORIDE (DOBUTAMINE HYDROCHLORIDE).
Inotropic Agent
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
Comprehensive clinical and safety monograph for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% (DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%).
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
Comprehensive clinical and safety monograph for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER (DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER).
DOBUTREX
Comprehensive clinical and safety monograph for DOBUTREX (DOBUTREX).
DOCA
Comprehensive clinical and safety monograph for DOCA (DOCA).
Mineralocorticoid
DOCEFREZ
Comprehensive clinical and safety monograph for DOCEFREZ (DOCEFREZ).
Cephalosporin Antibiotic
DOCETAXEL
Strong CYP3A4 inhibitors may increase levels and inducers may decrease levels Can cause severe fluid retention and myelosuppression.
Antimicrotubule Agent
DOCIVYX
Comprehensive clinical and safety monograph for DOCIVYX (DOCIVYX).
DOCOSANOL
Comprehensive clinical and safety monograph for DOCOSANOL (DOCOSANOL).
Antiviral Agent
DODEX
Comprehensive clinical and safety monograph for DODEX (DODEX).
Vitamin B12 Supplement
DOFETILDE
Comprehensive clinical and safety monograph for DOFETILDE (DOFETILDE).
Class III Antiarrhythmic
DOFETILIDE
Many drugs are contraindicated including verapamil and cimetidine as they inhibit secretion and increase levels Can cause life-threatening ventricular arrhythmias particularly torsades de pointes.
Antiarrhythmic (Class III)
DOJOLVI
Comprehensive clinical and safety monograph for DOJOLVI (DOJOLVI).
Triglyceride Replacement
DOLENE
Comprehensive clinical and safety monograph for DOLENE (DOLENE).
Opioid Analgesic
DOLENE AP-65
Comprehensive clinical and safety monograph for DOLENE AP-65 (DOLENE AP-65).
Opioid Analgesic Combination
DOLISHALE
Comprehensive clinical and safety monograph for DOLISHALE (DOLISHALE).
DOLOBID
Comprehensive clinical and safety monograph for DOLOBID (DOLOBID).
Nonsteroidal Anti-inflammatory Drug
DOLOPHINE HYDROCHLORIDE
Comprehensive clinical and safety monograph for DOLOPHINE HYDROCHLORIDE (DOLOPHINE HYDROCHLORIDE).
DOLUTEGRAVIR
Comprehensive clinical and safety monograph for DOLUTEGRAVIR (DOLUTEGRAVIR).
Integrase Strand Transfer Inhibitor Antiretroviral
DOLUTEGRAVIR AND LAMIVUDINE
Trimethoprim/sulfamethoxazole increases lamivudine exposure Severe acute exacerbations of hepatitis B have been reported upon discontinuation.
NRTI
DOLUTEGRAVIR SODIUM
Comprehensive clinical and safety monograph for DOLUTEGRAVIR SODIUM (DOLUTEGRAVIR SODIUM).
DOLUTEGRAVIR SODIUM AND ABACAVIR SULFATE AND LAMIVUDINE
DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE
Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
DOLUTEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
DOLUTEGRAVIR;LAMIVUDINE;TENOFOVIR ALAFENAMIDE
DOMEBORO
Comprehensive clinical and safety monograph for DOMEBORO (DOMEBORO).
Astringent
DONEPEZIL HYDROCHLORIDE
Other cholinergic agents can have additive effects Can cause nausea vomiting diarrhea and bradycardia.
Cholinesterase Inhibitor
DOPAMINE HYDROCHLORIDE
MAOIs can cause severe hypertension Extravasation can cause tissue necrosis and sloughing.
Catecholamine
DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%
DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5%
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
DOPAR
Comprehensive clinical and safety monograph for DOPAR (DOPAR).
Dopamine Precursor
Showing 2151 - 2200 of 8245
